Exane Derivatives’s ContextLogic LOGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-466
Closed -$76.2K 1091
2021
Q3
$76.2K Buy
466
+268
+135% +$66.7K 0.02% 570
2021
Q2
$61.8K Buy
+198
New +$70.2K 0.01% 619

Other funds holding LOGC

Exane Derivatives's LOGC Position: Q4 2021 in Review

Exane Derivatives sold out of ContextLogic (LOGC) in Q4 2021, closing a stake of 466 shares — an estimated $76.2K sold.

Exane Derivatives first reported a position in LOGC in Q2 2021 and held it in 2 quarters. The position peaked at $76.2K in Q3 2021. 164 funds tracked by Wall St. Rank hold LOGC as of Q4 2021.

  • Exane Derivatives reported no remaining ContextLogic position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 466 ContextLogic shares in Q4 2021, an estimated $76.2K.
  • Exane Derivatives first reported a position in ContextLogic in Q2 2021 and held it in 2 quarters.
  • Exane Derivatives's ContextLogic position peaked at $76.2K in Q3 2021.
  • 164 funds tracked by Wall St. Rank held ContextLogic as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.